Zenith Revalued at Investorline

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

masila

Rank: Vice President [?]

Points: 818 [?]

Votes: 16 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Zenith Revalued at Investorline

posted on Aug 09, 2019 09:42AM

BMO Investorline periodically re-values the Zenith shares I hold. Right now, they are showing them at 2.64 CAD/share. Over at ITrade, they are still showing at $0.00.